Article
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.
Leukemia - 1 Dec 2006
Seedhouse C H, Hunter H M, Lloyd-Lewis B, Massip A-M, Pallis M, Carter G I, Grundy M, Shang S, Russell N H
Abstract excerpt
The presence of internal tandem duplications (ITD) mutations in the FMS-like tyrosine kinase 3 (FLT3) receptor influences the risk of relapse in acute myeloid leukaemia (AML). We have investigated DNA repair in FLT3-ITD and wild-type (WT) cells. Using the comet assay, we have demonstrated that the FLT3 inhibitor PKC412 significantly inhibits repair of DNA damage in the MV4-11-FLT3-ITD cell line and FLT3-ITD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.